Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice (Q73010520)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

main subject

vancomycin

0 references

Enterococcus faecalis

object named as

Enterococcus faecalis

1 reference

C O Onyeji

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Q Bui

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D P Nicolau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C H Nightingale

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

L Bow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

R Quintiliani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Antimicrobial Agents

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

301-309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

Increasing problems in the therapy of enterococcal infections.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Resistance of enterococci to glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Vancomycin resistance in the enterococcus. Relevance in pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Management of infections due to resistant enterococci: a review of therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Vancomycin-Resistant Enterococcus faecium in Hospitalized Children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Interferon-gamma effects on activities of gentamicin and vancomycin against Enterococcus faecalis resistant to the drugs: an in vitro study with human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Interferon-gamma and host antimicrobial defense: current and future clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Interferon-gamma enhances the effect of antimalarial chemotherapy in murine Plasmodium vinckei malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Activity of gamma interferon in combination with pyrimethamine or clindamycin in treatment of murine toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Enterococcal bacteremia: analysis of 75 episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Microbicidal activities of Salmonella typhimurium- and interferon-gamma-activated mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Inhibition of antipyrine metabolism by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Effects of cytokines on antiviral pharmacokinetics: an alternative approach to assessment of drug interactions using bioequivalence guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

The pharmacodynamics of aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900055-2

7 January 2021

10.1016/S0924-8579(99)00055-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10493606%20AND%20SRC:MED&resulttype=core&format=json